Hemal Parmar

Hemal Parmar is a highly experienced pharmaceutical professional currently serving as a Senior Final Medical Signatory Manager at Otsuka Pharmaceutical Companies Europe since June 2023. With a robust background in medical advisory roles, Hemal has held various positions including Senior Medical Advisor for Sandoz, where responsibilities included leading UK medical initiatives in Oncology and Endocrinology, as well as serving as a medical lead for multiple therapies. Previous experience encompasses critical leadership roles at Grünenthal Group and Norgine, focusing on opioid analgesics and hepatology, respectively. Hemal's expertise also extends to line management, budget ownership, brand strategy, and mentoring within the ABPI/AQP framework. Educationally, Hemal holds an MPharm degree from King's College London.